THERIVA BIOLOGICS INC COM NEW - Stock (SYN)

CUSIP: 87164U201

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Stock
Total 13F shares
11,896,975
Share change
+4,666,508
Total reported value
$3,240,000
Price per share
$0.27
Number of holders
27
Value change
+$1,205,263
Number of buys
15
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q4 2021

As of 31 Dec 2021, THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,896,975 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., TRUIST FINANCIAL CORP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MSD Partners, L.P., Virtu Financial LLC, CITADEL ADVISORS LLC, NORTHERN TRUST CORP, and BLAIR WILLIAM & CO/IL. This page lists 27 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.